These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 8851644)

  • 1. Gender differences in presentation of chronic major depression.
    Kornstein SG; Schatzberg AF; Yonkers KA; Thase ME; Keitner GI; Ryan CE; Schlager D
    Psychopharmacol Bull; 1995; 31(4):711-8. PubMed ID: 8851644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender differences in treatment response to sertraline versus imipramine in patients with nonmelancholic depressive disorders.
    Baca E; Garcia-Garcia M; Porras-Chavarino A
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):57-65. PubMed ID: 14687858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical and psychometric diagnosis of depression in patients in general medicine].
    Ruiz A; Silva H; Miranda E
    Rev Med Chil; 2001 Jun; 129(6):627-33. PubMed ID: 11510202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical features of bipolar depression: a comparison with matched major depressive disorder patients.
    Mitchell PB; Wilhelm K; Parker G; Austin MP; Rutgers P; Malhi GS
    J Clin Psychiatry; 2001 Mar; 62(3):212-6; quiz 217. PubMed ID: 11305713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative meta-analysis of Clinical Global Impressions change in antidepressant trials.
    Spielmans GI; McFall JP
    J Nerv Ment Dis; 2006 Nov; 194(11):845-52. PubMed ID: 17102709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and demographic factors associated with DSM-IV melancholic depression.
    Khan AY; Carrithers J; Preskorn SH; Lear R; Wisniewski SR; John Rush A; Stegman D; Kelley C; Kreiner K; Nierenberg AA; Fava M
    Ann Clin Psychiatry; 2006; 18(2):91-8. PubMed ID: 16754414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features and functioning of patients with minor depression.
    Howland RH; Schettler PJ; Rapaport MH; Mischoulon D; Schneider T; Fasiczka A; Delrahiem K; Maddux R; Lightfoot M; Nierenberg AA
    Psychother Psychosom; 2008; 77(6):384-9. PubMed ID: 18716424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reliability and validity of the Turkish version of the Hamilton Depression Rating Scale.
    Akdemir A; Türkçapar MH; Orsel SD; Demirergi N; Dag I; Ozbay MH
    Compr Psychiatry; 2001; 42(2):161-5. PubMed ID: 11244153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of the five-factory inventory in characterizing patients with major depressive disorder.
    Petersen T; Bottonari K; Alpert JE; Fava M; Nierenberg AA
    Compr Psychiatry; 2001; 42(6):488-93. PubMed ID: 11704941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Depressive symptomatology and sleep apnea syndrome].
    Pochat MD; Ferber C; Lemoine P
    Encephale; 1993; 19(6):601-7. PubMed ID: 12404778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compliance with antidepressants in a primary care setting, 2: the influence of gender and type of impairment.
    Demyttenaere K; Enzlin P; Dewé W; Boulanger B; De Bie J; De Troyer W; Mesters P
    J Clin Psychiatry; 2001; 62 Suppl 22():34-7. PubMed ID: 11599646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic validity of assessment scales for depression in patients with schizophrenia.
    Kim SW; Kim SJ; Yoon BH; Kim JM; Shin IS; Hwang MY; Yoon JS
    Psychiatry Res; 2006 Sep; 144(1):57-63. PubMed ID: 16904189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treating depressed primary care patients improves their physical, mental, and social functioning.
    Coulehan JL; Schulberg HC; Block MR; Madonia MJ; Rodriguez E
    Arch Intern Med; 1997 May; 157(10):1113-20. PubMed ID: 9164377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Residual symptoms after a treated major depressive disorder: in practice ambulatory observatory carried out of city].
    Mouchabac S; Ferreri M; Cabanac F; Bitton M
    Encephale; 2003; 29(5):438-44. PubMed ID: 14615693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Open-label study of s-citalopram therapy of chronic fatigue syndrome and co-morbid major depressive disorder.
    Amsterdam JD; Shults J; Rutherford N
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):100-6. PubMed ID: 17804135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression.
    Malhi GS; Ng F; Berk M
    Aust N Z J Psychiatry; 2008 Apr; 42(4):346-9. PubMed ID: 18330778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Depression during interferon therapy in chronic hepatitis C patients--a prospective study].
    Otsubo T; Miyaoka H; Kamijima K; Onuki M; Ishii M; Mitamura K
    Seishin Shinkeigaku Zasshi; 1997; 99(3):101-27. PubMed ID: 9136611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder.
    Alpert JE; Franznick DA; Hollander SB; Fava M
    J Clin Psychiatry; 2004 Aug; 65(8):1069-75. PubMed ID: 15323591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depression in methadone maintenance treatment patients: rate and risk factors.
    Peles E; Schreiber S; Naumovsky Y; Adelson M
    J Affect Disord; 2007 Apr; 99(1-3):213-20. PubMed ID: 17055063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor structure and diagnostic efficiency of the BDI-II in treatment-seeking substance users.
    Seignourel PJ; Green C; Schmitz JM
    Drug Alcohol Depend; 2008 Mar; 93(3):271-8. PubMed ID: 18093749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.